Retevmo (selpercatinib) 40 mg/80mg capsules, dosage, Side Effects & Price

 Retevmo (selpercatinib) is a prescription medication used to treat certain types of thyroid cancer and non-small cell lung cancer (NSCLC) that have specific genetic mutations. It is taken orally in the form of capsules.


The recommended dosage of Retevmo depends on the patient's body weight and medical history. For the treatment of thyroid cancer, the recommended dose is 120 mg taken orally twice daily (total of 240 mg per day) with food. For the treatment of NSCLC, the recommended dose is 160 mg taken orally twice daily (total of 320 mg per day) with food.


Retevmo works by blocking the activity of specific proteins that promote the growth and spread of cancer cells. By blocking the activity of these proteins, Retevmo can slow down or stop the growth of the cancer cells.


Common side effects of Retevmo include diarrhea, nausea, vomiting, constipation, fatigue, and decreased appetite. Retevmo can also cause serious side effects, such as high blood pressure, liver problems, and heart problems. Patients should inform their healthcare provider immediately if they experience any of these symptoms or side effects.


It is important to discuss any potential risks and benefits of Retevmo with your healthcare provider before starting treatment. You should also inform your healthcare provider if you have a history of liver or heart problems, as well as any medications you are currently taking.

Comments

Popular posts from this blog

Tofacitinib Tablet 5 mg , Price & side Effects

Carfilzomib Injection 60 mg Price & Side Effects

Enhertu Injection 100 mg Price & Side Effects